Literature DB >> 12686053

Psoriasis.

Mark Lebwohl1.   

Abstract

Recent breakthroughs in the treatment of psoriasis have led to improved understanding of the pathogenesis of this disease. Activation of T lymphocytes leading to release of cytokines results in proliferation of keratinocytes. Several new biological therapies have been developed, which target specific steps in the pathogenesis of psoriasis. With these new treatments, variable degrees of clearing occur. Initial data suggest improved safety over older agents such as methotrexate and ciclosporin, but long-term data are necessary. Enhancements in topical therapy and phototherapy have also increased the armamentarium of treatments available for this disorder.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12686053     DOI: 10.1016/S0140-6736(03)12954-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  142 in total

1.  Pharmacokinetics of oral fumarates in healthy subjects.

Authors:  Nicolle H R Litjens; Jacobus Burggraaf; Elisabeth van Strijen; Co van Gulpen; Herman Mattie; Rik C Schoemaker; Jaap T van Dissel; H Bing Thio; Peter H Nibbering
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

2.  A practical approach to screening psoriasis patients for therapy with biologic agents.

Authors: 
Journal:  J Clin Aesthet Dermatol       Date:  2008-09

Review 3.  [The educational program for the management of psoriasis vulgaris according to the rules of the Task Force on Dermatological Prevention: current status].

Authors:  T Werfel; E Breitbart; A Kleinheinz; U Gieler; G Schmid-Ott
Journal:  Hautarzt       Date:  2006-10       Impact factor: 0.751

4.  Polymorphisms of the IL23R gene are associated with psoriasis but not with immunoglobulin A nephropathy in a Hungarian population.

Authors:  Eniko Safrany; Marta Szell; Veronika Csongei; Luca Jaromi; Csilla Sipeky; Titanilla Szabo; Lajos Kemeny; Judit Nagy; Bela Melegh
Journal:  Inflammation       Date:  2011-12       Impact factor: 4.092

Review 5.  Immunopathogenesis of psoriasis.

Authors:  Brian J Nickoloff; Jian-Zhong Qin; Frank O Nestle
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

Review 6.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.

Authors:  Aaron J Schetter; Niels H H Heegaard; Curtis C Harris
Journal:  Carcinogenesis       Date:  2009-12-02       Impact factor: 4.944

Review 7.  Common clinical features and disease mechanisms of psoriasis and psoriatic arthritis.

Authors:  Wendy Myers; Mobolaji Opeola; Alice B Gottlieb
Journal:  Curr Rheumatol Rep       Date:  2004-08       Impact factor: 4.592

Review 8.  Immunology of psoriasis.

Authors:  Michelle A Lowes; Mayte Suárez-Fariñas; James G Krueger
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

9.  Novel immunobiologics for psoriasis.

Authors:  Nilanjan Ghosh; P N Singh; Vikas Kumar
Journal:  Indian J Pharmacol       Date:  2008-06       Impact factor: 1.200

10.  Infliximab for the treatment of plaque psoriasis.

Authors:  Jennifer S Gall; Robert E Kalb
Journal:  Biologics       Date:  2008-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.